Erenumab

AbMole BioScience

Erenumab

9

1582205-90-0

Chemical

Research Use Only

Erenumab is a first-in-class fully human monoclonal CGRP antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the research of episodic migraine.

Please store the product under the recommended conditions in the Certificate of Analysis.

12352200